Related references
Note: Only part of the references are listed.The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis
Wael F. Ismaiel et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)
Evaluating and evolving a screening library in academia: the St Jude approach
Gisele Nishiguchi et al.
DRUG DISCOVERY TODAY (2021)
Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative Bacteria
Miranda J. Wallace et al.
ACS INFECTIOUS DISEASES (2020)
SARS-CoV2 and immunosuppression: A double-edged sword
Quirino Lai et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Structure and Function of Δ9-Fatty Acid Desaturase
Kohjiro Nagao et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery
Annick Menetrey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Bart Jan Kullberg et al.
CLINICAL INFECTIOUS DISEASES (2019)
Affinity Purification and Single-Molecule Analysis of Integral Membrane Proteins from Crude Cell-Membrane Preparations
Anders Lundgren et al.
NANO LETTERS (2018)
Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids
Cristina Lazzarini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Echinocandins in antifungal pharmacotherapy
Akash Patil et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes
Arielle Butts et al.
MSPHERE (2017)
Translational control of lipogenic enzymes in the cell cycle of synchronous, growing yeast cells
Heidi M. Blank et al.
EMBO JOURNAL (2017)
SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A
Chelsi D. Cassilly et al.
PLOS ONE (2016)
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
Visesato Mor et al.
MBIO (2015)
The evolution of drug resistance in clinical isolates of Candida albicans
Christopher B. Ford et al.
ELIFE (2015)
The mTOR Inhibitor Rapamycin Synergizes with a Fatty Acid Synthase Inhibitor to Induce Cytotoxicity in ER/HER2-Positive Breast Cancer Cells
Chen Yan et al.
PLOS ONE (2014)
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Benjamin Matteson Vincent et al.
PLOS BIOLOGY (2013)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
Annette C. Reboli et al.
BMC INFECTIOUS DISEASES (2011)
Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?
Joshua B. Parsons et al.
CURRENT OPINION IN MICROBIOLOGY (2011)
Molecular organization and force-generating mechanism of dynein
Hitoshi Sakakibara et al.
FEBS JOURNAL (2011)
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
Daniel H. Kett et al.
CRITICAL CARE (2011)
A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Fatty Acid Synthase Impacts the Pathobiology of Candida parapsilosis In Vitro and during Mammalian Infection
Long Nam Nguyen et al.
PLOS ONE (2009)
Inhibitors of Fabl, an enzyme drug target in the bacterial fatty acid biosynthesis pathway
Hao Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
The multienzyme architecture of eukaryotic fatty acid synthases
Marc Leibundgut et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
Inhibition of the fungal fatty acid synthase type I multienzyme complex
Patrik Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fatty acid synthesis and elongation in yeast
Oksana Tehlivets et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Architecture of a fungal fatty acid synthase at 5 Å resolution
S Jenni et al.
SCIENCE (2006)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Membrane proteins, lipids and detergents: not just a soap opera
AM Seddon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Dosage-dependent functions of fatty acid desaturase Ole1p in growth and morphogenesis of Candida albicans
S Krishnamurthy et al.
MICROBIOLOGY-SGM (2004)
Candida albicans genome sequence: a platform for genomics in the absence of genetics
FC Odds et al.
GENOME BIOLOGY (2004)
CT2108A and B: New fatty acid synthase inhibitors as antifungal agents
JA Laakso et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Fatty acid synthase inhibitors from plants: Isolation, structure elucidation, and SAR studies
XC Li et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Purification of a large protein using ion-exchange membranes
HW Yang et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
A downstream regulatory element located within the coding sequence mediates autoregulated expression of the yeast fatty acid synthase gene FAS2 by the FAS1 gene product
P Wenz et al.
NUCLEIC ACIDS RESEARCH (2001)
Assessing risk factors for systemic fungal infections
J Maertens et al.
EUROPEAN JOURNAL OF CANCER CARE (2001)
Share Paper
